Skip to content

Influence of modafinil in the treatment of premature ejaculation

Influence of modafinil in the treatment of premature ejaculation: a randomized, double-blind, placebo-controlled clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20090304001743N15
Enrollment
56
Registered
2020-05-01
Start date
2020-09-22
Completion date
Unknown
Last updated
2020-05-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature ejaculation. Premature ejaculation

Interventions

Intervention 1: Intervention group: Modafinil tablets 100 mg 4 to 6 hours before intercourse. Intervention 2: Control group: placebo tablets 4 to 6 hours before intercourse.

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Premature ejaculation, based on the criteria of the DSM – 5 Married and having at least 6 months continuous sexual intercourse with a sexual partner Life long premature ejaculation Signed written informed consent

Exclusion criteria

Exclusion criteria: Currently under further treatments for premature ejaculation Erectile dysfunction or other sexual disorders Other psychiatric disorders such as Major depressive disorder bipolar disorders, anxiety disorders, post-traumatic stress disorders, or personality disorders Chronic diseases such as diabetes, hypertension, endocrine system disease

Design outcomes

Primary

MeasureTime frame
Premature ejaculation profile score. Timepoint: Before the intervention, 4 weeks after the intervention. Method of measurement: Premature ejaculation profile Questionnaire.

Secondary

MeasureTime frame
Intravaginal ejaculation latency time. Timepoint: Before the intervention,4 weeks s after intervention. Method of measurement: By a stopwatch.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad haghighi

Hamedan University of Medical Sciences

haghighi@umsha.ac.ir+98 81 3827 1066

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026